Correlation Between Cardiff Oncology and BridgeBio Pharma
Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiff Oncology and BridgeBio Pharma, you can compare the effects of market volatilities on Cardiff Oncology and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and BridgeBio Pharma.
Diversification Opportunities for Cardiff Oncology and BridgeBio Pharma
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Cardiff and BridgeBio is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and BridgeBio Pharma go up and down completely randomly.
Pair Corralation between Cardiff Oncology and BridgeBio Pharma
Given the investment horizon of 90 days Cardiff Oncology is expected to under-perform the BridgeBio Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Cardiff Oncology is 1.25 times less risky than BridgeBio Pharma. The stock trades about -0.7 of its potential returns per unit of risk. The BridgeBio Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 3,301 in BridgeBio Pharma on January 14, 2025 and sell it today you would earn a total of 90.00 from holding BridgeBio Pharma or generate 2.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardiff Oncology vs. BridgeBio Pharma
Performance |
| Timeline |
| Cardiff Oncology |
| BridgeBio Pharma |
Cardiff Oncology and BridgeBio Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardiff Oncology and BridgeBio Pharma
The main advantage of trading using opposite Cardiff Oncology and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.| Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
| BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |